Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I B Hirsch

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Diabetes Care|June 2, 2000
Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 DiabetesR E Ratner, I B Hirsch, J L Neifing, et al.
Metabolism: Clinical and Experimental|September 14, 2001
Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetesR Juneja, I B Hirsch, R G Naik, et al.
The American Journal of Physiology|May 1, 1991
Catecholamines in prevention of hypoglycemia during exercise in humansJ C Marker, I B Hirsch, L J Smith, et al.
The American Journal of Physiology|May 1, 1991
Insulin and glucagon in prevention of hypoglycemia during exercise in humansI B Hirsch, J C Marker, L J Smith, et al.
The Journal of Family Practice|August 18, 2001
Improving the quality of outpatient care for older patients with diabetes: lessons from a comparison of rural and urban communitiesR A Rosenblatt, L M Baldwin, L Chan, et al.
Obesity Science & Practice|April 26, 2019
Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5)S S Ahmadi, K Filipsson, H Dimenäs, et al.
Diabetes, Obesity & Metabolism|May 29, 2013
Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short-acting GLP-1 analogue versus progression to basal-bolus therapyI B Hirsch, J B Buse, J Leahy, et al.
Bone Marrow Transplantation|April 5, 2016
Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipientsC Espina, I Jenkins, L Taylor, et al.
Diabetes Care|August 14, 1998
Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind studyP A Hollander, S C Elbein, I B Hirsch, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 2020
Characteristics of adult- compared to childhood-onset type 1 diabetesA Casu, L G Kanapka, N C Foster, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Diabetes Care|June 2, 2000
Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 DiabetesR E Ratner, I B Hirsch, J L Neifing, et al.
Metabolism: Clinical and Experimental|September 14, 2001
Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetesR Juneja, I B Hirsch, R G Naik, et al.
The American Journal of Physiology|May 1, 1991
Catecholamines in prevention of hypoglycemia during exercise in humansJ C Marker, I B Hirsch, L J Smith, et al.
The American Journal of Physiology|May 1, 1991
Insulin and glucagon in prevention of hypoglycemia during exercise in humansI B Hirsch, J C Marker, L J Smith, et al.
The Journal of Family Practice|August 18, 2001
Improving the quality of outpatient care for older patients with diabetes: lessons from a comparison of rural and urban communitiesR A Rosenblatt, L M Baldwin, L Chan, et al.
Obesity Science & Practice|April 26, 2019
Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5)S S Ahmadi, K Filipsson, H Dimenäs, et al.
Diabetes, Obesity & Metabolism|May 29, 2013
Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short-acting GLP-1 analogue versus progression to basal-bolus therapyI B Hirsch, J B Buse, J Leahy, et al.
Bone Marrow Transplantation|April 5, 2016
Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipientsC Espina, I Jenkins, L Taylor, et al.
Diabetes Care|August 14, 1998
Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind studyP A Hollander, S C Elbein, I B Hirsch, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 2020
Characteristics of adult- compared to childhood-onset type 1 diabetesA Casu, L G Kanapka, N C Foster, et al.
Pageof 6